Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice

Journal of Applied Toxicology

Volumn 32, Issue 11, 2012, Pages 890-899

  Xue, Yuying ^a   Zhang, Shanshan ^a   Huang, Yanmei ^a   Zhang, Ting ^a   Liu, Xiaorun ^a   Hu, Yuanyuan ^a   Zhang, Zhiyong ^b   Tang, Meng ^a  

^a Southeast University   (China)

^b INSTITUTE OF HIGH ENERGY PHYSICS   (China)

Author keywords

Acute toxic effects; Gender related biokinetics; Mice; Silver nanoparticles; Tissue distribution

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; LACTATE DEHYDROGENASE; PROTEIN; SILVER NANOPARTICLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BIOKINETICS; CHEMICAL, PHYSICAL AND MATHEMATICAL PHENOMENA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FEMALE; HISTOPATHOLOGY; INFLAMMATION; KIDNEY; LIVER; LIVER CELL; LUNG; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SPLEEN;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAVENOUS; KINETICS; MALE; MASS SPECTROMETRY; METAL NANOPARTICLES; MICE; MICE, INBRED ICR; NANOPARTICLES; SEX FACTORS; SILVER; TISSUE DISTRIBUTION;

MUS;

EID: 84866863235     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2742     Document Type: Article

References (41)

1. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM., Schlager JJ, Hong Y. 2008. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol. Appl. Pharmacol. 233: 404-410.
2. AshaRani PV, Hande MP, Valiyaveettil S. 2009. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 10: 65.
3. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. 2004. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15: 79-86.
4. Bell RA, Kramer JR. 1999. Structural chemistry and geochemistry of silver-sulfur compounds: Critical review. Environ. Toxicol. Chem. 18: 9-22.
5. Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N, Bergey EJ, Prasad PN, Stachowiak MK. 2005. Organically modified silica nanoparticles: A nonviral vector for in vivo gene delivery and expression in the brain. Proc. Natl. Acad. Sci. 32: 11539-11544.
6. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. 2005. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 88: 412-419.
7. Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, Nga TT, Van Vinh Chau N, Tuan PQ, Page AL, Ochiai RL, Schultsz C, Wain J, Bhutta ZA, Parry CM, Bhattacharya SK, Dutta S, Agtini M, Dong B, Honghui Y, Anh DD, Canh do G, Naheed A, Albert MJ, Phetsouvanh R, Newton PN, Basnyat B, Arjyal A, La TT, Rang NN, Phuong le T, Van Be Bay P, Von Seidlein L, Dougan G, Clemens JD, Vinh H, Hien TT, Chinh NT, Acosta CJ, Farrar J, Dolecek C. 2007. Antimicrobial drug resistance of Salmonella enterica serovar typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob. Agents Chemother. 51: 4315-4323.
8. Chen D, Xi T, Bai J, Wang J. 2009. Nanosilver subchronic toxicity and silver distribution in different rat tissues. J. Clin. Rehabil. Tissue Engin. Res. 13: 3181-3183.
9. Chen X, Schluesener HJ. 2008. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. 176: 1-12.
10. Chen Z, Chen H, Meng H, Xing G, Gao X, Sun B, Shi X, Yuan H, Zhang C, Liu R, Zhao F, Zhao Y, Fang X. 2008. Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol. Appl. Pharmacol. 230: 364-371.
11. Choi JE, Kim S, Ahn JH, Youn P, Kang JS, Park K, Yi J, Ryu DY. 2010. Induction of oxidative stress and apoptosis by silver nanoparticles in the liver of adult zebrafish. Aquat. Toxicol. 100: 151-159.
12. Chrastina A, Schnitzer JE. 2010. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int. J. Nanomedicine 5: 653-659.
13. Coto-García AM, Sotelo-González E, Fernández-Argüelles MT, Pereiro R, Costa-Fernández JM, Sanz-Medel A. 2011. Nanoparticles as fluorescent labels for optical imaging and sensing in genomics and proteomics. Anal. Bioanal. Chem. 399: 29-42.
14. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ. 2005. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnology 3: 6.
15. Furchner JE, Richmond CR, Drake GA. 1968. Comparative metabolism of radionuclides in mammals - IV. Retention of sliver-110m in the mouse, rat, monkey, and dog. Health Phys.. 15: 505-514.
16. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ. 2008. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 179: 130-139.
17. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 19: 975-983.
18. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung JH, Sung KS, Yu IJ. 2007. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 19: 857-871.
19. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK, Lee YS, Jeong DH, Cho MH. 2007. Antimicrobial effects of silver nanoparticles. Nanomedicine 3: 95-101.
20. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20: 575-583.
21. Kvitek L, Vanickova M, Panacek A, Soukupova J, Dittrich M, Valentova E, Prucek R, Bancirova M, Milde D, Zborit R. 2009. Initial study on the toxicity of silver nanoparticles (NPs) against Paramecium caudatum. J. Phys. Chem. C 113: 4296-4300.
22. Lankveld DPK, Oomen AG, Krystek P, Neigh A, Troost-de Joog A, Noorlander CW, Van Eijkeren JCH, Geertsma RE, De Jong WH. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31: 8350-8361
23. Lanone S, Rogerieux F, Geys J, Dupont A, Maillot-Marechal E, Boczkowski J, Lacroix G, Hoet P. 2009. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part. Fibre Toxicol. 6: 14.
24. Liu Z, Liu Y, Yang H, Yang Y, Shen G, Yu R. 2005. A phenol biosensor based on immobilizing tyrosinase to modified core-shell magnetic nanoparticles supported at a carbon paste electrode. Anal. Chim. Acta 533: 3-9.
25. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, Mortensen A, Lam HR, Larsen EH. 2011. Distribution of silver in rats following 28days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 8: 18.
26. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM. 2007. Silver nanoparticles: partial oxidation and antibacterial activities. J. Biol. Inorg. Chem. 12: 527-534.
27. Miura N, Shinohara Y. 2009. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem. Biophys. Res. Commun. 390: 733-737.
28. Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. 2009. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medicaldevices containing silver. Int. J. Antimicrob. Agents 34: 103-110.
29. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC.
30. Park EJ, Choi K, Park K. 2011. Induction of inflammatory responses and gene expression by intratracheal instillation of silver nanoparticles in mice. Arch. Pharm. Res. 34: 299-307.
31. Salata O. 2004. Application of nanoparticles in biology and medicine. J. Nanobiotechnology 2: 1-6.
32. Samuel U, Guggenbichler JP. 2004. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int. J. Antimicrob. Agents 23: S57-S78.
33. Sayes CM, Reed KL, Warheit DB. 2007. Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 97: 163-180.
34. Seagrave J, McDonald JD, Mauderly JL. 2005. In vitro versus in vivo exposure to combustion emissions. Exp. Toxicol. Pathol. 57: 233-238.
35. Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, Thorne PS. 2011. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part. Fibre Toxicol. 8: 5.
36. Stern ST, McNeil SE. 2008. Nanotechnology safety concerns revisited. Toxicol. Sci. 101: 4-21.
37. Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Kim J, Kim TS, Chang HK, Lee EJ, Lee JH, Yu IJ. 2008. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. 20: 567-574.
38. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 109: 547-551.
39. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya RH. 2007. Functional finishing of cotton fabrics using silver nanoparticles. J. Nanosci. Nanotechnol. 7: 1893-1897.
40. Woodrow Wilson International Center for Scholars. 2011. Project on Emerging Nanotechnologies, Consumer Products Inventory of Nanotechnology Products. Available from: http://www.nanotechproject.org/inventories/consumer/analysis_draft/ (accessed 24 November 2011).
41. Xue Y, Tang M. 2009. Research progresses in biological effects of nanosilver (in Chinese). J. Southeast Univ. (Nat. Sci. Edn) 39: 1315-1320.